Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02970669

Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. — AWAKE-HF  

Heart Failure, Reduced Ejection Fraction Clinical Trial

Official title:
Multicenter, Randomized, Double-blind, Double Dummy, Parallel Group, Active-controlled 8-week Study and 8-week Open Label Extension to Evaluate the Effect of Initiation of Sacubitril/Valsartan on Objective Measures of Waking Activity and Sleep, as Health-related Quality of Life Functions in Subjects With Heart Failure and Reduced Ejection Fraction (AWAKE-HF).

Clinical Trial Summary

The purpose of this study was to investigate the effects of initiation of sacubitril/valsartan vs enalapril treatment on objective measures of both waking activity and sleep in subjects with heart failure with reduced ejection fraction.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02970669
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 4
Start date December 16, 2016
Completion date March 19, 2018
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05973591 - The Impact of Ivabradine on Left Ventricular Reverse Remodeling in Nonischemic Dilated Cardiomyopathy (NIDCM) on Current Medical Therapy Era
Recruiting NCT06108076 - Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes Early Phase 1
Completed NCT05250011 - Observation of Italian Patients With Heart Failure Being Treated With Dapagliflozin in Clinical Practice